4.2 Article

New answers to old questions from genome-wide maps of DNA methylation in hematopoietic cells

期刊

EXPERIMENTAL HEMATOLOGY
卷 42, 期 8, 页码 609-617

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2014.04.008

关键词

-

资金

  1. National Institutes of Health [DK092883, AG036562, CA183252]
  2. Waxman Cancer Research Foundation

向作者/读者索取更多资源

DNA methylation is a well-studied epigenetic modification essential for efficient cellular differentiation. Aberrant DNA methylation patterns are a characteristic feature of cancer, including myeloid malignancies such as acute myeloid leukemia. Recurrent mutations in DNA-modifying enzymes were identified in acute myeloid leukemia and linked to distinct DNA methylation signatures. In addition, discovery of Tet enzymes provided new mechanisms for the reversal of DNA methylation. Advances in base-resolution profiling of DNA methylation have enabled a more comprehensive understanding of the methylome landscape in the genome. This review will summarize and discuss the key questions in the function of DNA methylation in the hematopoietic system, including where and how DNA methylation regulates diverse biological processes in the genome as elucidated by recent studies. (C) 2014 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据